Regulatory aspects of pharmacovigilance Pia Caduff and Deirdre McCarthy, UMC
What are safety communications? by Federica Castellani, EMA
Risk Communication the in the post-cox2 era by Fredric Bouder, HST
Risk management by Pia Caduff, UMC
Key considerations in risk management plans by Marten Lagendijk, EMA
Video lectures (optional) not included course
Overview of the new EMA pharmacovigilance regulations Peter Arlett, EMA
Effective communications – Part 1 and 2 by Bruce Hugman, UMC.
